Polypoidal Choroidal Vasculopathy
📧 Sign up to get email alerts when something new happens for Polypoidal Choroidal Vasculopathy.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2016-11-23Clinical Trial Update: Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation [Phase 4]
Phase 4 clinical trial evaluating intravitreal aflibercept injection for polypoidal choroidal vasculopathy with hemorrhage or exudation has …
-
CLINICAL_TRIALS trial_result · 2016-08-12Clinical Trial Update: Comparison of PDT Combination With Ranibizumab vs. Ranibizumab Monotherapy in Persistent PCV With Initial Loading Dose [Phase 4]
Phase 4 clinical trial update comparing photodynamic therapy plus ranibizumab versus ranibizumab alone in persistent polypoidal choroidal va…
-
CLINICAL_TRIALS research · 2016-06-29Clinical Trial Update: Angiographic Characteristics of CSC, PCV Patients and Thrombotic Bio-markers
This entry provides an update on a clinical trial examining angiographic features of central serous chorioretinopathy (CSC) and polypoidal c…
-
CLINICAL_TRIALS trial_result · 2016-06-17Clinical Trial Update: Short-term Efficacy of Intravitreal Afilibercept Depending on Subtypes of Polypoidal Choroidal Vasculopathy: Polypoidal Choroidal Neovascularization or Idiopathic Choroidal Vasculopathy
Clinical trial update assessing the short-term efficacy of intravitreal aflibercept in subtypes of Polypoidal Choroidal Vasculopathy (polypo…
-
CLINICAL_TRIALS trial_result · 2016-04-29Clinical Trial Update: Effect of Intravitreal VEGF-Trap Eye on Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 trial evaluating intravitreal VEGF Trap-Eye (aflibercept) for polypoidal choroidal vasculopathy and exudative age-related macular de…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2015-08-13Clinical Trial Update: Triple Treatment for Detachment of Retinal Pigment Epithelium Secondary to Polypoidal Choroidal Vasculopathy [Phase 4]
A Phase 4 clinical trial evaluating a triple treatment for detachment of the retinal pigment epithelium secondary to polypoidal choroidal va…
-
CLINICAL_TRIALS trial_result · 2014-11-05Clinical Trial Update: Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) [Phase 1]
This document reports the completion of a Phase 1 trial evaluating ranibizumab for polypoidal choroidal vasculopathy.
-
CLINICAL_TRIALS trial_result · 2014-10-15Clinical Trial Update: Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial) [Phase 4]
Phase 4 clinical trial update on intravitreal aflibercept (Eylea) for neovascular polypoidal choroidal vasculopathy (RIVAL trial).
-
CLINICAL_TRIALS trial_result · 2014-06-23Clinical Trial Update: Ranibizumab (Lucentis) for Polypoidal Choroidal Vasculopathy [Phase 1, Phase 2]
Clinical trial update for ranibizumab (Lucentis) investigating treatment of polypoidal choroidal vasculopathy across Phase 1 and Phase 2, wi…
-
CLINICAL_TRIALS trial_result · 2013-04-23Clinical Trial Update: iSONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV) [Phase 1]
Phase 1 trial of iSONEP for treating persistent pigment epithelial detachment in exudative age-related macular degeneration or polypoidal ch…
-
CLINICAL_TRIALS research · 2012-11-01Clinical Trial Update: IRay to Treat Polypoidal Choroidal Vasculopathy (PCV) Secondary to Age-Related Macular Degeneration (AMD [NA]
Clinical trial update indicates the IRay device is being explored to treat polypoidal choroidal vasculopathy secondary to age-related macula…
-
CLINICAL_TRIALS research · 2012-10-25Clinical Trial Update: Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy [Phase 1, Phase 2]
Phase 1/2 clinical trial update on treatments for exudative and vasogenic chorioretinal diseases including AMD variants and other CNV-relate…
-
CLINICAL_TRIALS trial_result · 2012-04-09Clinical Trial Update: Vascular Endothelial Growth Factor (VEGF) & LOC387715/HTRA1 Polymorphism in Polypoidal Choroidal Vasculopathy
This completed clinical trial studied the influence of VEGF and LOC387715/HTRA1 polymorphism in polypoidal choroidal vasculopathy, a conditi…
-
CLINICAL_TRIALS trial_result · 2011-11-01Clinical Trial Update: Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV) [Phase 2]
A Phase 2 clinical trial in Asian patients evaluated the safety and response of Fosbretabulin for Polypoidal Choroidal Vasculopathy, and the…
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: LOC387715/HTRA1 and the Combined Photodynamic Therapy With Intravitreal Bevacizumab in Polypoidal Choroidal Vasculopathy
This trial evaluates combining verteporfin photodynamic therapy with intravitreal bevacizumab to treat polypoidal choroidal vasculopathy, a …
-
CLINICAL_TRIALS trial_result · 2011-08-30Clinical Trial Update: LOC387715/HTRA1 Variants in Polypoidal Choroidal Vasculopathy in a Korean Population [NA]
A completed clinical trial investigated LOC387715/HTRA1 genetic variants in polypoidal choroidal vasculopathy among a Korean population. The…
-
CLINICAL_TRIALS research · 2011-05-30Clinical Trial Update: Aqueous Humor Level of Cytokines in Polypoidal Choroidal Vasculopathy and Change of Cytokines After Photodynamic Therapy [NA]
This clinical trial update examines aqueous humor cytokine levels in Polypoidal Choroidal Vasculopathy and how cytokines change after photod…
-
CLINICAL_TRIALS trial_result · 2011-03-31Clinical Trial Update: PDT Study for Exudative AMD With PCV [Phase 4]
Phase 4 clinical trial update on photodynamic therapy for exudative age-related macular degeneration with polypoidal choroidal vasculopathy;…
-
CLINICAL_TRIALS trial_result · 2011-01-25Clinical Trial Update: Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy [Phase 4]
Phase 4 trial evaluating verteporfin added to ranibizumab for symptomatic polypoidal choroidal vasculopathy; efficacy and safety results hav…
-
CLINICAL_TRIALS trial_result · 2011-01-06Clinical Trial Update: Response to Ranibizumab in Polypoidal Choroidal Vasculopathy (PCV)and SNPs
This completed clinical trial evaluates how patients with Polypoidal Choroidal Vasculopathy respond to ranibizumab, including potential asso…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy [Phase 1, Phase 2]
An update on a safety-focused clinical trial evaluating high-dose ranibizumab for polypoidal choroidal vasculopathy (Phase 1/2). The current…
-
CLINICAL_TRIALS trial_result · 2007-09-26Clinical Trial Update: Off-Label AVASTIN (BEVACIZUMAB) For Serosanguinous Maculopathy [Phase 3]
This document covers a Phase 3 trial evaluating off-label bevacizumab (Avastin) for serosanguinous maculopathy. The study targets choroidal …
-
CLINICAL_TRIALS trial_result · 2006-10-04Clinical Trial Update: Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy [NA]
Clinical trial update on intravitreal bevacizumab for polypoidal choroidal vasculopathy; the current status of the trial is unknown.